Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2000
08/31/2000DE19908762A1 Verwendung von Dienogest in hoher Dosierung Use of dienogest in high doses
08/31/2000DE19908567A1 New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases
08/31/2000DE19908537A1 Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas Use of 2-amino-thiazole polycyclic systems for the production of medicaments for the prophylaxis or treatment of obesity
08/31/2000DE19908535A1 Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas The use of polycyclic thiazole systems for the production of medicaments for the prophylaxis or treatment of obesity
08/31/2000DE19908487A1 Pharmazeutische Zubereitung enthaltend Dithranol Pharmaceutical composition containing dithranol
08/31/2000DE19908449A1 Kristallmodifikation C von Crystal modification of C 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
08/31/2000DE19908448A1 Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure Crystal modification D of 8-cyano-1-cyclopropyl-7- (1S, 6S-2,8-diazabicyclo [4.3.0) nonane-8-yl) -6-fluoro-1,4-dihydro-4-oxo-3 -chino incarbonsäure
08/31/2000DE19906979A1 Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Nikotinabhängigkeit Pharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence
08/31/2000DE19906974A1 Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung des Alkoholismus Pharmaceutical composition containing deoxypeganine for the treatment of alcoholism
08/31/2000DE19858005A1 Synthetisches Nucleinsäure-Partikel Synthetic nucleic acid particles
08/31/2000DE10008042A1 Neurokinin-1-Rezeptorantagonisten Neurokinin-1 receptor antagonists
08/31/2000CA2850318A1 Trpm-2 antisense therapy
08/31/2000CA2615684A1 Reovirus for the treatment of cellular proliferative disorders
08/31/2000CA2371876A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
08/31/2000CA2371814A1 Trpm-2 antisense therapy
08/31/2000CA2366951A1 Methods and compositions for altering mucus secretion
08/31/2000CA2366943A1 Dry acid-chitosan complexes
08/31/2000CA2366919A1 Novel sulfonamide compounds and uses thereof
08/31/2000CA2366747A1 Controlled release formulation for treating copd
08/31/2000CA2366697A1 Treatment regimen for hormone-sensitive cancers
08/31/2000CA2365793A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical composition containing them
08/31/2000CA2365026A1 Virus vector
08/31/2000CA2364949A1 Use of sulfamate derivatives for treating impulse control disorders
08/31/2000CA2364780A1 Enteral sorbefacients
08/31/2000CA2364754A1 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both
08/31/2000CA2364749A1 6-substituted-7-heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both
08/31/2000CA2364712A1 Platinum (ii) compounds
08/31/2000CA2363714A1 Avermectin aglycon synthase genes
08/31/2000CA2363621A1 A novel inhibitor of programmed cell death
08/31/2000CA2363605A1 Androgen-induced suppressor of cell proliferation and uses thereof
08/31/2000CA2363131A1 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
08/31/2000CA2363106A1 Mdm interacting protein and methods of use thereof
08/31/2000CA2363074A1 Treatment of infertility
08/31/2000CA2363036A1 Composition for the treatment of psoriasis
08/31/2000CA2362940A1 Treatment of infertility
08/31/2000CA2362906A1 Dna encoding snorf25 receptor
08/31/2000CA2362564A1 Topic tricyclic antidepressants as analgesics
08/31/2000CA2362047A1 Treatment regimen for prostate cancer, initiated after androgen ablative therapy has started
08/31/2000CA2361826A1 Antitumour synergistic composition
08/31/2000CA2360934A1 Polycyclo heterocyclic derivatives as antiinflammatory agents
08/31/2000CA2360528A1 Gabapentin derivative for preventing and treating visceral pain
08/31/2000CA2359891A1 Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof
08/31/2000CA2333955A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
08/30/2000EP1031626A1 Method for stabilising and/or isolating nucleic acids
08/30/2000EP1031575A1 Process for preparing growth hormone secretagogues
08/30/2000EP1031570A1 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency
08/30/2000EP1031569A1 Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and composition containing the same as active ingredient
08/30/2000EP1031564A1 Inhibitors of cellular nicotinamide mononucleotide formation and their use in cancer therapy
08/30/2000EP1031353A1 Antimycotic compositions
08/30/2000EP1031351A1 Leishmaniasis remedy containing glucopyranose derivative as the active ingredient
08/30/2000EP1031350A1 Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain
08/30/2000EP1031349A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
08/30/2000EP1031348A2 Interleukin-4 production inhibitors
08/30/2000EP1031345A1 Gel preparation containing polystyrene-sulfonates
08/30/2000EP1030935A1 Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression
08/30/2000EP1030919A2 Cdk2 protein and cdk2 protein complexes
08/30/2000EP1030916A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
08/30/2000EP1030915A1 A novel gene and uses therefor
08/30/2000EP1030914A2 Antisense oligonucleotides against tenascin for treating vitiligo
08/30/2000EP1030913A2 Nucleic acid catalysts with endonuclease activity
08/30/2000EP1030909A1 Immune activation by double-stranded polynucleotides
08/30/2000EP1030857A2 Adenosine a1 receptor agonists
08/30/2000EP1030856A2 Adenosine a1 receptor agonists
08/30/2000EP1030852A1 Oxazolidinone derivatives and pharmaceutical compositions
08/30/2000EP1030851A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity
08/30/2000EP1030842A1 Metalloproteinase inhibitors
08/30/2000EP1030841A1 Process for the preparation of 1,4-dihydropyridines and compounds used in this process
08/30/2000EP1030840A1 Cyclic amine derivatives and their use as drugs
08/30/2000EP1030839A1 Use of alkylated iminosugars to treat multidrug resistance
08/30/2000EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030835A2 Urea derivatives and their use as integrin inhibitors
08/30/2000EP1030834A1 Benzocycloheptene derivatives
08/30/2000EP1030686A2 Lyophilizate of lipid complex of water insoluble porphyrins
08/30/2000EP1030682A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
08/30/2000EP1030673A1 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
08/30/2000EP1030672A1 Method for treating attention deficit disorder
08/30/2000EP1030671A1 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
08/30/2000EP1030670A1 Use of vitamin d derivatives to enhance efficacy of cytotoxic agents
08/30/2000EP1030669A2 Progestogen-antiprogestogen regimens
08/30/2000EP1030668A1 Penetration enhancing and irritation reducing systems
08/30/2000EP1030667A1 Use of mirtazapine for treating sleep apneas
08/30/2000EP1030666A1 Novel use of compounds for anti-pruritic activity
08/30/2000EP1030665A1 Therapeutic uses of quinoline derivatives
08/30/2000EP1030664A1 Pharmaceutical compositions containing zafirlukast
08/30/2000EP1030663A1 Treatment of fibromyalgia and related disorders
08/30/2000EP1030662A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/30/2000EP1030661A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA 2? INHIBITORS
08/30/2000EP1030660A1 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof
08/30/2000EP1030659A1 (+)-ephedrine as a sympathomimetic drug
08/30/2000EP1030658A1 Method of building and maintaining bone
08/30/2000EP1030654A1 Omeprazole formulation
08/30/2000EP1030653A1 Dinitroaniline liposomal formulations and processes for their preparation
08/30/2000EP1030651A1 Novel oral dosage form for carvedilol
08/30/2000EP1030615A1 Spine distraction implant
08/30/2000EP1030567A1 System, method and composition for dialysis and shock treatment
08/30/2000EP1030547A1 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
08/30/2000EP1003465A4 Prevention/retardation of hair growth
08/30/2000EP0998251A4 Compositions and methods for inhibiting photoaging of skin
08/30/2000EP0836606B1 Condensed thiazole derivatives, having 5-ht receptor affinity
1 ... 6254 6255 6256 6257 6258 6259 6260 6261 6262 6263 6264 6265 6266 6267 6268 6269 6270 6271 6272 6273 6274 ... 7860